Company Overview and News

 
Casa Systems Q2 2018 Earnings Review

2018-08-16 seekingalpha
Yesterday on the 14th of August 2018, the 2nd quarter earnings for Casa Systems where released after the close of market. These earnings where initially quite disconcerting. This is because revenue was approximately $20m lower than analysts expected and FY18 revenue projections had been cut by about $50 million. After this information was released, the share price begun to decline significantly.
CASA

 
Why Casa Systems Is Wednesday’s Big Earnings Loser

2018-08-15 247wallst
When Casa Systems Inc. (NASDAQ: CASA) released its second-quarter financial results after the markets closed on Tuesday, the company posted $0.24 in earnings per share (EPS) and $68.7 million in revenue. The consensus estimates had called for $0.23 in EPS and $90.3 million in revenue. In the same period of last year, Casa Systems said it had EPS of $0.23 on $66.63 million in revenue.
CASA

 
Casa Systems, Inc. (CASA) CEO Jerry Guo on Q2 2018 Results - Earnings Call Transcript

2018-08-15 seekingalpha
Greetings, and welcome to the Casa Systems' Second Quarter 2018 Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator instructions] As a reminder, this conference is being recorded.
MQBKY CASA MS MCQEF MQG

 
CASA / Casa Systems, Inc. 10-Q (Quarterly Report)

2018-08-14 sec.gov
casa-10q_20180630.htm UNITED STATES
CASA

 
CASA / Casa Systems, Inc. 8-K (Current Report)

2018-08-14 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
CASA

16
Potentially Exciting And Undiscovered Gem?

2018-08-14 seekingalpha
Casa Systems is an interesting and high growth technology company that is worth looking into as the complexity of this investment may cause investors to overlook it.
ARRS GEC GE CHLKF CASA 0941 DCF CHL GNE MS

2
Casa Systems Announces Departure of Chief Financial Officer

2018-07-11 globenewswire - 2
ANDOVER, Mass., July 11, 2018 (GLOBE NEWSWIRE) -- Casa Systems, Inc. (Nasdaq:CASA), a leading provider of converged broadband infrastructure technology solutions for mobile, cable, and fixed networks, today announced that Gary Hall, Chief Financial Officer (CFO), has provided notice of his intent to leave the company effective August 10, 2018.
CASA ACLS

 
CASA / Casa Systems, Inc. 8-K (Current Report)

2018-07-11 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
CASA

7
Analysts Have 5 Key Tech Stocks to Buy Ahead of Earnings Season

2018-07-10 247wallst
The markets were looking strong on Tuesday ahead of earnings season. That said, the strength on Tuesday was far less broad than that seen on Monday. While some ongoing trade war concerns continue to weigh on investors, many analysts and investors alike are looking for the sweet spot in earnings, and Tuesday’s top analyst upgrades and downgrades included five major technology analyst calls that were having an impact on the shares.
WBA CASA CRM CMG AMT IMPV MU AAPL TRI MS

5
Top Analyst Upgrades and Downgrades: American Tower, AutoNation, Biogen, CarMax, Chipotle, eBay, PG&E, Walgreens, Zions and More

2018-07-10 247wallst
Stocks were indicated higher on Tuesday, although on a much more muted tune than the 320-point Dow Jones industrials gain and the 24-point gain on the S&P 500 seen on Monday. The prior trend of buying every dip and sell-off has been less reliable during most of 2018 than in prior years. Many investors now are considering how they want their investments positioned ahead of the midterm elections and also for the longer term into 2019 and beyond.
PCG HELE KMX CASA CMG AN AMT BIIB ABG TRI MS EBAY

 
Casa Systems to Showcase Innovative Core and Access Solutions that Transform All Broadband Networks to 5G at ANGA COM 2018

2018-06-11 globenewswire
ANDOVER, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Casa Systems (Nasdaq:CASA), a leading provider of converged broadband infrastructure technology solutions for mobile, cable, fixed and converged broadband networks today announced that it will demonstrate its innovative multi-service core and access network solutions at ANGA COM, June 12-14 in Cologne, Germany, in Hall 7, Stand #G11. In addition, Casa’s product and solution experts will participate in panels that explore network convergence, discuss lessons learned with virtual CCAP and Remote PHY, and share new Wi-Fi use cases, coverage and user experiences.
CASA

647
Stocks To Watch: Focus On E3, IHOP/b And The World Cup

2018-06-09 seekingalpha - 8
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GOOS GNK AINC CAT TWX DXCM PGR RH AXDX] OPRF AJG NKE SHAK AMZN SCVL AEP MYGN DCI MS VLKAY JBL TTWO CARB TREX FAST INCY PDYPF COMM AXDX NVMI TWC AVT RNG PAP AHBIF MSFT NFG PEG HRB PDYPY NMRK ULTA ADDYY ADP WDAY CASA ADBE GMVHF ATVI CGBD AMTD LII PRTY DIN EXC NEE DIS LUV EA ALGN BUD CMCSA O NEO FDX KFY RGEN EXAS FNSR XEL SIX TGT SCHW T ADPVV ETFC SNE PLAY CAKE CODI

642
Stocks To Watch: Focus On E3, IHopb And The World Cup

2018-06-09 seekingalpha - 3
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GOOS GNK AINC CAT TWX DXCM PGR RH AXDX] OPRF AJG NKE SHAK AMZN SCVL AEP MYGN DCI MS VLKAY JBL TTWO CARB TREX FAST INCY PDYPF COMM AXDX NVMI TWC AVT RNG PAP AHBIF MSFT NFG PEG HRB PDYPY NMRK ULTA ADDYY ADP WDAY CASA ADBE GMVHF ATVI CGBD AMTD LII PRTY DIN EXC NEE DIS LUV EA ALGN BUD CMCSA O NEO FDX KFY RGEN EXAS FNSR XEL SIX TGT SCHW T ADPVV ETFC SNE PLAY CAKE CODI

3
CASA / Casa Systems, Inc. FORM 8-K (Current Report)

2018-06-08 sec.gov - 3
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
CASA

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

18h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

Silicon Investor Message Boards

This table lists all message boards related to CASA / Casa Systems, Inc. on message board site Silicon Investor.

Casavant Mining Kimberlite International (CMKM) Casavant Mining Kimberlite International (CMKM) Casavant Mining Kimberlite International (CMKM) La casa de Panita La casa de Panita La casa de Panita
CUSIP: 14713L102